Vimarsana
Biggest News Aggregation in the World

Page 15 - Genscript Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genscript Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genscript Biotech Today - Breaking & Trending Today

GenScript Biotech collaborates with Singapore Institute of Technology - Vimarsana News

GenScript Biotech collaborates with Singapore Institute of Technology

GenScript Biotech collaborates with Singapore Institute of Technology

GenScript Biotech Collaborates with Singapore Institute of Technology on Talent Development and Applied Research Projects - Vimarsana News

GenScript Biotech Collaborates with Singapore Institute of Technology on Talent Development and Applied Research Projects

Singapore, May 26, 2022 /PRNewswire/ -- GenScript Biotech Collaborates with Singapore Institute of Technology on Talent Development and Applied Research Projects

GenScript, fellow NJ biotech partner on COVID-19 antibody test distribution - Vimarsana News

GenScript, fellow NJ biotech partner on COVID-19 antibody test distribution

Piscataway-based GenScript USA reached an agreement with Euroimmun US to distribute its COVID-19 antibody test in the U.S. and Canada.

Source: njbiz.com
Reviewing NRx Pharmaceuticals (NASDAQ:NRXP) & Legend Biotech (NASDAQ:LEGN) - Vimarsana News

Reviewing NRx Pharmaceuticals (NASDAQ:NRXP) & Legend Biotech (NASDAQ:LEGN)

Legend Biotech (NASDAQ:LEGN – Get Rating) and NRx Pharmaceuticals (NASDAQ:NRXP – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends. Volatility & Risk Legend Biotech has a beta of -0.1, […]

Gene Editing Tools Market Growing at a CAGR of 18.8% Over The Forecast Period 2022-2029 - Vimarsana News

Gene Editing Tools Market Growing at a CAGR of 18.8% Over The Forecast Period 2022-2029

According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 481.3 Mn in terms of value in 2022.The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18.8% during the period 202...